Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.05 (0.55%)
Spread: 0.70 (7.955%)
Open: 9.10
High: 9.15
Low: 8.70
Prev. Close: 9.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMilller Chairman sells over 11m pounds in shares

Tue, 23rd Jul 2013 16:21

Graham Mackay, the Chairman of SABMiller who is currently on a medical leave of absence due to a brain tumour, has sold over 11m pounds-worth of shares in the company.Mackay sold a total of 350,000 shares between July 16-18th through three separate transactions, the firm revealed on Tuesday. He sold: 138,000 at 3,266.8p each; 50,000 at 3,250.74p each; and another 162,000 at 3,251.4p each.He pocketed £11.4m through the sale, leaving his holding at just over 1.4m shares.The director first joined the beverages company back in 1978 when it was known as South African Breweries and was its Chief Executive Officer (CEO) at the time of its listing in London in 1999. The company was renamed to SABMiller following the purchase of US group Miller Brewing Company in 2002.Mackay was appointed Executive Chairman in July 2012 but, after being diagnosed with a brain tumour in April, the firm accelerated the promotion of Alan Clark to CEO with Mackay taking a more back-seat position of Non-Executive Chairman. At the time of Clark's appointment, the company said it would keep Mackay's position under review until the outcome of his treatment following surgery in April.SABMiller's share price has increased by nearly 16% since the start of 2013.Top Director BuysVerona Pharma (VRP) Director name: Mr Stuart BottomlyAmount purchased: 3,000,000 @ 1.67p Value: £50,100Scancell Holdings (SCLP) Director name: Ms Katherine Cornish-BowdenAmount purchased: 45,000 @ 32.00p Value: £14,400Top Director SellsSABMiller (SAB) Director name: Mr Graham MackayAmount sold: 162,000 @ 3,251.40p Value: £5,267,268SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 138,000 @ 3,266.80p Value: £4,508,184SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 50,000 @ 3,250.74p Value: £1,625,370Accsys Technologies (AXS) Director name: Mr Paul Hugh Anthony Clegg Amount sold: 1,500,000 @ € 0.14 Value: € 204,000Accsys Technologies (AXS) Director name: Mr Hans Pauli Amount sold: 330,000 @ € 0.14 Value: € 44,880Accsys Technologies (AXS) Director name: Mr William Bickerton RudgeAmount sold: 119,686 @ € 0.14 Value: € 16,277BC
More News
19 Feb 2021 12:40

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

Read more
17 Feb 2021 16:22

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

Read more
3 Feb 2021 14:53

Scancell ends clinical development partnership with Cancer Research UK

(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.

Read more
3 Feb 2021 11:20

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

Read more
3 Feb 2021 11:11

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

Read more
3 Feb 2021 09:48

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Read more
29 Jan 2021 15:05

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

Read more
21 Dec 2020 19:39

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 10:26

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Read more
18 Dec 2020 10:17

Scancell selects Covid-19 vaccine candidate for development and trials

(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.

Read more
16 Dec 2020 09:21

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

Read more
14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Read more
25 Nov 2020 16:44

UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million

UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million

Read more
17 Nov 2020 15:40

UK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves

UK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.